Navigation Links
uBiome Appoints John Rakow as Interim Chief Executive Officer
Date:5/2/2019

uBiome, the leader in microbial genomics, today announced that its Board of Directors has appointed John Rakow, the Company’s General Counsel, as Interim Chief Executive Officer of uBiome, effective immediately. The Company’s Co-CEOs and Founders, Jessica Richman and Zac Apte, are currently on administrative leave. There will also be an independent investigation into uBiome’s billing practices to be overseen by a Special Committee of the Board.

Mr. Rakow, who joined uBiome in fall 2018, is a seasoned attorney with more than 35 years of experience providing legal counsel and leadership as a member of senior management teams of both public and privately-held companies. His background includes expertise across legal, human resource, compliance and strategy matters in a range of industries including technology, professional services, government contracting, manufacturing, engineering and insurance. In addition, he has served in both private practice and as a federal government lawyer.

Mr. Rakow commented, “As interim CEO of uBiome, I want all of our stakeholders to know that we intend to cooperate fully with government authorities and private payors to satisfactorily resolve the questions that have been raised, and we will take any corrective actions that are needed to ensure we can become a stronger company better able to serve patients and healthcare providers.”

”My confidence is based on the significant clinical evidence and medical literature that demonstrates the utility and value of uBiome’s products as important tools for patients, health care providers and our commercial partners. We look forward to continuing to demonstrate this clinical utility and value at a time of growing demand in the market,” added Mr. Rakow.    

About uBiome
Founded in 2012, uBiome is the leader in microbial genomics. uBiome combines precision sequencing with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has 13 granted and 47 allowed patents, and a robust pipeline of patent applications, on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.

uBiome’s products include SmartGut™ a microbiome test, which evaluates the gut microbiome for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, a women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.

uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.

Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.

Read the full story at https://www.prweb.com/releases/ubiome_appoints_john_rakow_as_interim_chief_executive_officer/prweb16281825.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. uBiome Appoints Dr. Steven Medwell, MD, Distinguished Colorectal Surgeon, to its Medical Advisory Board
2. uBiome Appoints Kathie Swift, MS, RDN, FAND, Co-founder of the Integrative and Functional Nutrition Academy, to its Scientific Advisory Board
3. uBiome Appoints Dr. Jonathan Braun, MD, PhD, Prominent UCLA Physician-Researcher, to its Scientific Advisory Board
4. uBiome Appoints Dr. Donnica Moore, MD, Women's Health Expert and Advocate, to its Medical Advisory Board
5. uBiome Appoints Leading Biochemist Dr. Joseph DeRisi to Board of Directors
6. uBiome Appoints Dr. Catherine Lozupone, PhD, Respected Microbiologist, to its Scientific Advisory Board
7. uBiome Appoints Dr. Jill Carnahan, MD, Functional Medicine Expert, to its Medical Advisory Board
8. uBiome Appoints Dr. Emeran Mayer, MD, World-Renowned Gastroenterologist and Neuroscientist, to its Medical Advisory Board
9. uBiome Appoints Dr. Brandon Wuerth, MD, Founder of IBDwatch, to its Medical Advisory Board
10. uBiome Appoints Dr. Amir Zarrinpar, MD, PhD, Assistant Professor in the Division of Gastroenterology at UC San Diego, to its Medical Advisory Board
11. uBiome Receives Patent for Microbiome-Derived Diagnostics and Therapeutics for Immune-Microbial Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2019)... FREDERICK, Md. (PRWEB) , ... ... ... a biotechnology market disrupter and leading supplier of innovative human mesenchymal stem/stromal ... industry’s first human umbilical cord (hUC) MSC paired cell and media system ...
(Date:8/29/2019)... ... August 29, 2019 , ... Advancements ... robotics platform in an upcoming episode, which is scheduled to broadcast 1Q/2020. Check ... and commercialization of cost-effective robotic surgical solutions for the treatment of patients suffering ...
(Date:8/27/2019)... ... 26, 2019 , ... Shoreline Biome , a microbiome research company that ... McKenzie as its CEO and Karen Woodward as its VP of Business Development. ... for its products and expand the company’s sales worldwide. , Prior to joining Shoreline ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... STATION, N.J. (PRWEB) , ... September 16, 2019 , ... ... clearing reagents and kits that allow for the complete 3D characterization of tissues through ... Visikol has transitioned into an imaging, image analysis and advanced cell culture focused contract ...
(Date:9/17/2019)... ... September 16, 2019 , ... ... with the China Focus @ Biotech Week Boston, a forum organized by MyBioGate, ... in healthcare innovation. , After a careful process of evaluation, twelve companies out ...
(Date:9/11/2019)... ... September 09, 2019 , ... Suvoda LLC , ... drug supply chain management, today announced its new technology partnership with Veeva ... “The integration between Veeva Vault EDC and our IRT will enable sponsors and ...
(Date:9/11/2019)... SOMERSET, N.J. (PRWEB) , ... September 10, 2019 ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health ... Pharma Forum, to be held at the Bausparkasse Schwäbisch Hall AG, Schwabisch Hall, ...
Breaking Biology Technology: